Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 04:00PM ET
3.04
Dollar change
+0.01
Percentage change
0.50
%
IndexRUT P/E- EPS (ttm)-1.92 Insider Own8.71% Shs Outstand104.90M Perf Week-27.10%
Market Cap317.35M Forward P/E- EPS next Y-0.69 Insider Trans-0.04% Shs Float95.76M Perf Month-11.88%
Income-184.44M PEG- EPS next Q-0.25 Inst Own80.34% Short Float13.27% Perf Quarter-53.66%
Sales247.00M P/S1.28 EPS this Y42.40% Inst Trans-4.06% Short Ratio3.98 Perf Half Y0.50%
Book/sh-1.55 P/B- EPS next Y38.87% ROA-36.38% Short Interest12.70M Perf Year-58.97%
Cash/sh1.77 P/C1.72 EPS next 5Y11.60% ROE-2096.78% 52W Range2.30 - 9.74 Perf YTD-65.42%
Dividend Est.- P/FCF- EPS past 5Y0.57% ROI-62.94% 52W High-68.80% Beta0.84
Dividend TTM- Quick Ratio3.05 Sales past 5Y815.27% Gross Margin70.15% 52W Low32.17% ATR (14)0.31
Dividend Ex-Date- Current Ratio4.12 EPS Y/Y TTM61.49% Oper. Margin-67.21% RSI (14)31.61 Volatility3.58% 6.82%
Employees597 Debt/Eq- Sales Y/Y TTM15.33% Profit Margin-74.67% Recom3.00 Target Price5.16
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q77.56% Payout- Rel Volume0.86 Prev Close3.03
Sales Surprise-12.17% EPS Surprise-37.55% Sales Q/Q5.47% EarningsNov 07 AMC Avg Volume3.19M Price3.04
SMA20-19.71% SMA50-34.94% SMA200-32.17% Trades Volume2,736,343 Change0.50%
Date Action Analyst Rating Change Price Target Change
Jan-29-24Downgrade Mizuho Buy → Neutral $16 → $9
Jan-09-24Downgrade Goldman Buy → Neutral $30 → $8
Aug-16-23Upgrade Exane BNP Paribas Underperform → Neutral $20
Oct-11-22Initiated Morgan Stanley Equal-Weight $27
Sep-22-22Initiated Goldman Buy $33
Oct-25-21Downgrade Wells Fargo Overweight → Equal Weight $35 → $17
Oct-15-20Reiterated Needham Buy $36 → $42
Aug-11-20Resumed Mizuho Buy $32
Mar-23-20Downgrade Goldman Buy → Neutral $32 → $15
Dec-02-19Initiated Goldman Buy
Dec-09-24 09:12AM
08:30AM
Nov-07-24 06:20PM
04:05PM
Sep-27-24 09:35AM
01:14AM Loading…
Sep-17-24 01:14AM
Sep-12-24 01:12AM
Aug-29-24 09:55AM
Aug-13-24 09:55AM
Aug-12-24 09:27AM
08:15AM
08:00AM
Aug-08-24 06:00PM
04:05PM
Aug-01-24 04:05PM
06:00AM Loading…
Jul-11-24 06:00AM
Jun-14-24 04:05PM
May-28-24 04:05PM
May-24-24 09:35AM
May-22-24 08:50PM
May-12-24 04:00PM
May-10-24 04:30PM
03:04PM
11:36AM
10:20AM
May-09-24 06:25PM
04:06PM
04:05PM
May-02-24 04:05PM
Apr-12-24 08:00AM
04:05PM Loading…
Mar-27-24 04:05PM
Mar-04-24 09:25AM
06:37AM
Mar-02-24 08:23AM
Feb-29-24 06:41AM
Feb-28-24 04:43PM
04:05PM
Feb-21-24 08:01AM
08:00AM
Feb-02-24 08:00AM
Feb-01-24 08:00AM
Jan-08-24 08:00AM
Nov-09-23 07:05PM
09:54AM
Nov-08-23 07:00PM
04:06PM
04:05PM
Nov-06-23 08:00AM
Nov-01-23 08:00AM
Oct-26-23 08:00AM
Oct-14-23 01:15PM
Sep-19-23 04:18PM
09:00AM
Sep-06-23 02:27PM
12:43PM
Aug-29-23 12:43AM
Aug-22-23 10:43AM
08:00AM
Aug-21-23 04:09AM
Aug-14-23 04:03PM
08:00AM
Aug-08-23 06:15PM
04:05PM
Aug-03-23 09:19AM
Aug-01-23 08:00AM
Jul-29-23 11:39AM
Jul-13-23 03:00PM
09:35AM
Jun-29-23 06:20AM
Jun-21-23 08:41PM
May-23-23 04:05PM
May-17-23 06:35AM
May-16-23 02:34AM
May-10-23 10:45AM
May-09-23 06:05PM
04:05PM
06:25AM
May-02-23 10:01AM
08:00AM
Apr-18-23 08:41AM
Apr-05-23 08:00AM
Apr-04-23 11:15PM
Mar-30-23 08:00AM
Mar-29-23 05:36AM
Mar-07-23 08:00AM
Mar-03-23 08:11PM
Mar-01-23 10:33AM
Feb-28-23 07:45PM
04:06PM
04:05PM
Feb-27-23 08:00AM
06:21AM
Feb-24-23 05:10PM
07:48AM
Feb-23-23 08:00AM
Feb-22-23 10:00AM
Feb-21-23 04:05PM
Feb-20-23 10:00AM
Feb-03-23 02:15PM
Feb-02-23 12:00PM
Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hollander DavidCMO & Global Therapeutics LeadNov 18 '24Sale4.173,90816,296104,945Nov 19 04:31 PM
Jordan EricaChief Commercial OfficerApr 16 '24Sale3.802,3929,096114,864Apr 17 04:34 PM
Sjuts Dustin SPresidentMar 18 '24Sale5.049,21146,446167,550Mar 19 06:45 PM
Moxie DwightCLO & GCMar 18 '24Sale5.048,12540,971137,815Mar 19 06:44 PM
Schilke TobinCFOMar 18 '24Sale5.049,36147,204192,666Mar 19 06:44 PM
Foley Mark JCEOMar 06 '24Buy6.9830,000209,4001,015,468Mar 08 04:33 PM